
Please try another search
Here are four stocks with buy rank and strong income characteristics for investors to consider today, December 4th:
Western Union Company (NYSE:WU) (WU): This payment services provider has witnessed the Zacks Consensus Estimate for its current year earnings advancing 5.2% over the last 60 days.
Western Union Company (The) Price and Consensus
This Zacks Rank #2 (Buy) company has a dividend yield of 3.55%, compared with the industry average of 0.00%. Its five-year average dividend yield is 3.17%.
Western Union Company (The) Dividend Yield (TTM)
HollyFrontier Corporation (HFC): This independent petroleum refiner has witnessed the Zacks Consensus Estimate for its current year earnings advancing 33.1% over the last 60 days.
HollyFrontier Corporation Price and Consensus
This Zacks Rank #2 (Buy) company has a dividend yield of 2.98%, compared with the industry average of 1.90%. Its five-year average dividend yield is 3.31%.
HollyFrontier Corporation Dividend Yield (TTM)
Arbor Realty Trust, Inc. (ABR): This specialized real estate finance company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.7% over the last 60 days.
Arbor Realty Trust Price and Consensus
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 8.79%, compared with the industry average of 3.95%. Its five-year average dividend yield is 7.97%.
The Buckle, Inc. (BKE): This retailer of casual apparel has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
Buckle, Inc. (The) Price and Consensus
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 4.64%, compared with the industry average of 0.00%. Its five-year average dividend yield is 2.84%.
Buckle, Inc. (The) Dividend Yield (TTM)
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
The fortune of Nvidia (NASDAQ:NVDA) is closely tied to Big Tech hyperscalers. Although the AI/GPU designer didn’t name its largest clients in the latest 10-K filing on Wednesday,...
In a market fraught with uncertainty, investors often seek refuge in defensive-minded stocks that offer stability and resilience. Two such stalwarts, Johnson & Johnson and...
The United States is the largest exporter of liquefied natural gas (LNG), having surpassed Australia and Qatar in 2023. The United States exports an estimated 12.5 billion cubic...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.